JNJ Stock Analysis: Bullish Analyst Ratings vs Mixed Price Targets in 2026

# Johnson & Johnson Stock Analysis: Q1 2026 Trading Update & Bullish Analyst Forecasts | JNJ Stock Podcast **Description:** Dive into the latest Johnson & Johnson (JNJ) stock analysis with comprehensive trading data and analyst insights for 2026. In this episode, we break down JNJ's current trading price of $243.86, recent price action between $240.51-$244.21, and below-average trading volume of 7.22 million shares indicating cautious market sentiment. Discover why top-tier analysts are bullish on Johnson & Johnson stock, with HSBC setting a $280 price target, Citigroup at $274, and RBC Capital maintaining an Outperform rating at $255. Learn about JNJ's impressive 2026 guidance of $99.5-100 billion in operational sales, beating consensus expectations through strong Innovative Medicine and MedTech segment growth. This podcast episode covers: - Real-time JNJ stock trading metrics and volume analysis - Multiple analyst rating upgrades from HSBC, Citigroup, and Barclays - Johnson & Johnson's $584 billion market cap positioning - Attractive 2.14% dividend yield for income investors - Long-term price forecasts through 2030, projecting potential upside to $320 - Comprehensive fundamental analysis of JNJ's business segments Perfect for dividend investors, healthcare stock enthusiasts, and those seeking defensive blue-chip investment opportunities. Subscribe for regular stock market updates and analysis. #JohnsonAndJohnson #JNJStock #StockMarket #DividendStocks #HealthcareStocks #InvestingPodcast #StockAnalysis #MarketUpdate2026 For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.